Received May 31, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | JN94E | IM / LA |
patient reports symptoms of persistent headaches, subjective fevers, body rash (red, blistering) and pain.
HTN, Hyperlipidemia, anxiety disorder
anti-hypertensive medications, anti-anxiety medications
NKDA prior to this
per patient's report, she did have a reaction to 1st dose but it was not as severe.